Background This study examines the limitations and complex management problems
associated with the use of tiered-therapy, implantable cardioverter-defibrillators (ICDs) …

To determine the incidence of complications of third‐generation implantable cardioverter
defibrillator (ICD) therapy, 144 patients were prospectively studied who underwent first …

The need for thoracotomy in usually high risk patients has limited the use of the implantable
cardioverter defibrillator. Initial clinical results with endocardial and subcutanous patch …

To determine whether implantable cardioverter-defibrillator (ICD) therapy is influenced by
new technological advances, we studied the follow-up of 480 patients who underwent ICD …

In order to determine the incidence of complications of impJantable cardioverter defibrillator
(ICD) therapy, 241 patients with a total of 353 ICD implantations were followed for 24±20 …

Background The purpose of the present report was to document clinical experience derived
from the implantation of 2834 epicardial and endocardial cardioverter-defibrillators (ICDs) in …

An automatic cardioverter-defibrillator could be implanted using an endocardial defibrillation
lead system (consisting of a tripolar defibrillation electrode catheter in conjunction with an …

Implantation of the first automatic defibrillator occurred in February 1980. Incorporation of
cardioversion capability in 1982 resulted in the AICD™ automatic implantable cardioverter …

Background: Although more than 150,000 implantable cardioverter defibrillators (ICDs) are
implanted yearly worldwide, only few studies systematically examined complications of ICD …

Objectives. This report describes the sensing/pacing lead complications that developed
during a worldwide clinical trial of a new impiantable cardioverter-defibrillator. Background …